- Home
- REE vs FEMY Comparison
REE vs FEMY Comparison
Compare REE & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REE
- FEMY
- Stock Information
- Founded
- REE 2011
- FEMY 2004
- Country
- REE Israel
- FEMY United States
- Employees
- REE N/A
- FEMY N/A
- Industry
- REE Auto Manufacturing
- FEMY Medical/Dental Instruments
- Sector
- REE Consumer Discretionary
- FEMY Health Care
- Exchange
- REE Nasdaq
- FEMY Nasdaq
- Market Cap
- REE 18.5M
- FEMY 18.6M
- IPO Year
- REE N/A
- FEMY 2021
- Fundamental
- Price
- REE $0.67
- FEMY $0.38
- Analyst Decision
- REE Strong Buy
- FEMY Strong Buy
- Analyst Count
- REE 2
- FEMY 3
- Target Price
- REE $11.75
- FEMY $7.33
- AVG Volume (30 Days)
- REE 60.3K
- FEMY 1.6M
- Earning Date
- REE 09-25-2025
- FEMY 08-08-2025
- Dividend Yield
- REE N/A
- FEMY N/A
- EPS Growth
- REE N/A
- FEMY N/A
- EPS
- REE N/A
- FEMY N/A
- Revenue
- REE $183,000.00
- FEMY $1,887,016.00
- Revenue This Year
- REE $6,661.20
- FEMY $103.55
- Revenue Next Year
- REE $2,240.01
- FEMY $148.13
- P/E Ratio
- REE N/A
- FEMY N/A
- Revenue Growth
- REE N/A
- FEMY 98.61
- 52 Week Low
- REE $0.53
- FEMY $0.31
- 52 Week High
- REE $11.72
- FEMY $1.80
- Technical
- Relative Strength Index (RSI)
- REE 42.94
- FEMY 24.33
- Support Level
- REE $0.64
- FEMY $0.36
- Resistance Level
- REE $0.77
- FEMY $0.42
- Average True Range (ATR)
- REE 0.04
- FEMY 0.06
- MACD
- REE -0.00
- FEMY -0.01
- Stochastic Oscillator
- REE 22.50
- FEMY 16.48
About REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is in early stages of commercialization and develop and produce software-defined vehicle (SDV) technology that manages vehicle operations and features through proprietarily-developed software. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.
About FEMY Femasys Inc.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.